13 Million Adults Delaying or Skipping Meds Due to Costs
Drug unaffordability is an issue regardless of insurance status and across private, public payers
First Long-Acting Injectable Approved for HIV PrEP
Apretude, administered every two months, is approved in adults and adolescents at risk for HIV infection
Biden Outlines Measures to Fight Omicron, Pleads With Americans to Get Vaccinated
Included in the battle plan announced Tuesday are measures to distribute 500 million free rapid COVID-19 tests to the public
Symptom Presentation Varies by SARS-CoV-2 Variant
During first wave of COVID-19, cough occurred first in the United States, while fever occurred first in China
Factors ID’d for Severe GI Effects of SARS-CoV-2 in Children
Among children infected with SARS-CoV-2, 9.5 percent have severe GI effects, such as disseminated adenomesenteritis, appendicitis, pancreatitis
Molnupiravir Cuts Risk for Severe COVID-19 Illness in Adults
Risk for hospitalization or death lower in at-risk adults with mild-to-moderate COVID-19 receiving oral therapy with molnupiravir versus placebo
Pediatricians Can Play Key Role in HIV Testing, Prophylaxis
All youth ages 15 years or older should be offered routine screening at least once; those at increased risk should be rescreened
Pandemic Worsened Mental Health, Social Risk in Minority Children
Depression/anxiety problems increased for urban, racial- and ethnic-minority children during versus six months before the pandemic
Test-to-Stay Strategy Seems Effective for Saving In-Person Learning
Studies show secondary attack rate of 1.5 percent in Lake County, Illinois; no tertiary transmission in 20 identified outbreaks in Los Angeles
Moderna Says Its Booster Protects Well Against Omicron
Experts agree that booster shots are the best defense against the omicron variant
